Hepatocyte-derived soluble factors regulate proliferation and autocrine growth factor expression in colon cancer cell lines of varying liver- colonizing capability

Tumor Biology

Volumn 21, Issue 4, 2000, Pages 187-196

  Zvibel, Isabel ^a   Brill, Shlomo ^a   Papa, Moshe ^a,b   Halpern, Zamir ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Colon carcinomas; Erb B2; Liver; Metastasis

Indexed keywords

AMPHIREGULIN; GROWTH FACTOR; MESSENGER RNA; PROTEIN;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RAT;

EID: 0033937726     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030125     Document Type: Article

References (23)

1. Paget S: Lancet 1889;1:571.
2. Nicolson GL: Metastatic tumor cell interactions with endothelium, basement membrane and tissue. Curr Opin Cell Biol 1989;1:1009-1019.
3. Zvibel I, Kraft A: Extracellular matrix and metastasis; in Zern MA, Reid LM (eds): Extracellular Matrix: Its Chemistry, Biology, and Pathobiology. New York, Dekker, 1993, vol 22, pp 559-580.
4. Zvibel I, Brill S, Halpern Z, Papa M: Hepatocyte extracellular matrix modulates expression of growth factors and growth factor receptors in human colon cancer cells. Exp Cell Res 1998;245:123-131.
5. Nicolson GL, Dulski KM: Organ specificity of metastatic tumor colonization is related to organ-selective growth properties of malignant cells. Int J Cancer 1986;38: 289-294.
6. Szaniawska B, Majewski S, Kaminski MJ, Noremberg K, Swierz M, Janik P: Stimulatory and inhibitory activities of lung-conditioned medium on the growth of normal and neoplastic cells in vitro. J Natl Cancer Inst 1985;75:303-306.
7. Radinsky R: Paracrine growth regulation of colon carcinoma organ-specific metastasis. Cancer Metastasis Rev 1995;12:345-361.
8. Ciardello F, Kim N, Saeki T, Dono R, Persico MG, Plowman GD, Garrigues J, Radke S, Todaro GJ, Salomon DS: Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc Natl Acad Sci USA 1991;88: 7792-7796.
9. Ciardello F, Tortora G, Bianco C, Selvam MP, Basolo F, Fontanini G, Pacifico F, Normanno N, Brandt R, Persico GM, Salomon DS, Bianco AR: Inhibition of criptoexpression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides. Oncogene 1994;9:291-298.
10. Radinsky R: Molecular mechanisms for organ-specific colon carcinoma metastasis. Eur J Cancer 1995;31: 1091-1095.
11. Kapitanovic S, Radosevic S, Kapitanovic M, Andelinovic S, Ferencic Z, Tavassoli M, Primorac D, Sonicki Z, Spaventi S, Pavelic K, Spaventi R: The expression of p185 (HER-2/ neu) correlates with the stage of disease and survival in colorectal cancer. Gastroenterology 1997;112: 1103-1113.
12. Johnson GR, Saeki T, Gordon AW, Shoyab M, Salomon DS, Stromberg K: Autocrine action of amphiregulin in a colon carcinoma cell line and immunochemical localization of amphiregulin in human colon. J Cell Biol 1992;118:741-751.
13. Block GD, Locker J, Bowen WC, Petersen BE, Katyal S, Strom SC, Riley T, Howard TA, Michalopoulos GK: Population expansion, clonal growth and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF-α in a chemically defined (HGM) medium. J Cell Biol 1996;132:1133-1149.
14. Berry MN, Friend DJ: High-yield preparation of isolated rat liver parenchymal cells: A biochemical and fine structure study. J Cell Biol 1969;43:506-520.
15. Chomczynsky P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
16. Feinberg AP, Vogelstein B: A technique for radiolabeling DNA restriction endonudease fragments to high specific activity. Anal Biochem 1984;137:266-267.
17. Doerr R, Zvibel I, Chiuten D, D'Olimpio J, Reid LM: Clonal growth of tumors on tissue-specific biomatrices and correlation with organsite specificity of metastases. Cancer Res 1989;49:384-392.
18. Beerli RR, Hynes NE: Epidermal growth factor-related peptides activate distinct subsets of erbB receptors and differ in their biological activities. J Biol Chem 1996;271: 6071-6076.
19. Bacus SS, Huberman E, Chin D, Kiguchi K, Simpson S, Lippman M, Lupu R: A ligand for the erb-B2 oncogene product (gp30) induces differentiation of human breast cancer cells. Cell Growth Differ 1992;3: 401-411.
20. Bacus SS, Yarden Y, Oren M, Chin DM, Lyass L, Zelnick CR, Kazarov A, Toyofuku W, Gray-Bablin J, Beerli RR, Hynes NE, Nikiforov M, Haffner R, Gudkov A, Keyomarsi K: Neu differentiation factor (heregulin) activates a p53-dependent pathway in cancer cells. Oncogene 1996;12:2535-2547.
21. Marikovsky M, Lavi S, Pinkas-Kramarski R, Karunagaran D, Liu N, Wen D, Yarden Y: Erb-B3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes. Oncogene 1995;10: 1403-1411.
22. Lonardo F, Di Marco E, King CR, Pierce JH, Segatto O, Aaronson SA, Di Fiore PP: The normal erb-b2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand. New Biol 1990;2:992-1003.
23. Huang F, Sauma S, Yan Z, Friedman E: Colon absorptive cells lose proliterative response to TGF-α as they differentiate. Exp Cell Res 1995;219:8-14.